Concepedia

Tricia Protack

TP

Statistics

Publications

12

Citations

339

H-Index

11

Active since

2013

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (India)

Biocon (India)

Tricia Protack is an author at Bristol-Myers Squibb (United States) specializing in antiviral pharmacology, antiretroviral therapy, and drug discovery.

Publications per year

2013–2022

12

Publications

12

Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage

Beata Nowicka-Sans, Tricia Protack, Zeyu Lin et al. · Antimicrobial Agents and Chemotherapy · 2016 · 65 citations · Full text

, , +17

Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity

Alicia Regueiro‐Ren, Zheng Liu, Yan Chen et al. · ACS Medicinal Chemistry Letters · 2016 · 54 citations

, , +16

Inhibitors of HIV-1 maturation: Development of structure–activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids

Jacob J. Swidorski, Zheng Liu, Sing‐Yuen Sit et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 35 citations

, , +17

Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors

Li Guo, Nicholas A. Meanwell, Mark Krystal et al. · Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

, , +17

C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors

Zheng Liu, Jacob J. Swidorski, Beata Nowicka-Sans et al. · Bioorganic & Medicinal Chemistry · 2016 · 28 citations

, , +11

1–5 of 12